Westholme

Westholme Therapeutics is a biotechnology company specializing in the development of next-generation RNA therapeutics using circular RNA (circRNA) technology. The company's platform focuses on improving the stability and translation efficiency of RNA medicines compared to traditional linear mRNA. Westholme aims to address unmet medical needs in areas such as protein replacement therapy, vaccines, and immunotherapy. By leveraging its proprietary circRNA design and delivery systems, the company seeks to create long-lasting and potent therapeutic effects. Headquartered in Beijing with operations in Boston, Westholme is backed by prominent life science investors to advance its pipeline toward clinical validation.